About Sinopharm Pharmaceutical
Sinopharm Pharmaceutical was a publicly listed company based in Dongcheng (China) founded in 1999. It serves as a distributor of generic drugs. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Distribution and Generic Drugs.
Company details
Sinopharm Pharmaceutical serves as a distributor of generic drugs through providing healthcare solutions, producing pharmaceutical products, distribution, and generic drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Dongcheng, China
- Stage Public
- SectorsHealthcare
- Website cncm.com.cn
- Legal Name China National Medicines Corporation Ltd. Class A
- Annual Revenue$7.48 B (USD)3.69as on Dec 31, 2025
- Net Profit$285.67 M (USD)-0.18as on Dec 31, 2025
- EBITDA$324.24 M (USD)-3.42as on Dec 31, 2025
IPO & Listings of Sinopharm Pharmaceutical
Sinopharm Pharmaceutical is a publicly listed company on the SSE with ticker symbol 600511 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Nov 2002
- Listed onSSE: 600511
- Listed entityChina National Medicines Corporation Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE000001D56
- Share price27.39 CNY (+2.93% on the day) · 2026-10-14
- Market capitalisation20,077,325,044.00 CNY
- Price to earnings10.7
- EPS (diluted, trailing year)2.56 CNY
- Dividend yield3.01%
- Volume (last session)7,540,100
Financials of Sinopharm Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 52.36B CNY | 2.00B CNY | 2.27B CNY |
| 2024 | 50.50B CNY | 2.00B CNY | 2.35B CNY |
| 2023 | 49.61B CNY | 2.15B CNY | 2.58B CNY |
| 2022 | 45.42B CNY | 1.96B CNY | 2.42B CNY |
| 2021 | 46.38B CNY | 1.75B CNY | 2.24B CNY |
Detailed financial statements for Sinopharm Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Sinopharm Pharmaceutical
Websites that share an audience with Sinopharm Pharmaceutical (cncm.com.cn).
Websites whose visitors overlap most with Sinopharm Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sinopharm.com | 100% | 51.6K | #492,192 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sinopharm Pharmaceutical
Complete news archive for Sinopharm Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sinopharm Pharmaceutical
Sinopharm Pharmaceutical was founded in 1999.
Sinopharm Pharmaceutical is headquartered in Dongcheng, China. It is registered at Dongcheng, Beijing, China.
Annual revenue of Sinopharm Pharmaceutical is $7.48B as on Dec 31, 2025.
Sinopharm Pharmaceutical serves as a distributor of generic drugs through providing healthcare solutions, producing pharmaceutical products, distribution, and generic drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Yes, Sinopharm Pharmaceutical is publicly traded on SSE under the ticker symbol 600511.